Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
Gonsalves WI, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Siddiqui MA, Kyle RA, Gertz MA, Rajkumar SV, Kumar SK. Gonsalves WI, et al. Among authors: nandakumar b. Am J Hematol. 2020 Mar;95(3):310-315. doi: 10.1002/ajh.25709. Epub 2020 Jan 8. Am J Hematol. 2020. PMID: 31867775 Free PMC article. Clinical Trial.
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
Nandakumar B, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Siddiqui M, Zeldenrust S, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Nandakumar B, et al. Clin Lymphoma Myeloma Leuk. 2020 Jan;20(1):53-56. doi: 10.1016/j.clml.2019.09.624. Epub 2019 Oct 9. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31685378 Free PMC article.
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.
Evans LA, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Go R, Russell S, Lust JA, Lin Y, Siddiqui M, Kyle RA, Gertz MA, Rajkumar SV, Kumar SK, Gonsalves WI. Evans LA, et al. Among authors: nandakumar b. Am J Hematol. 2020 Jun;95(6):637-642. doi: 10.1002/ajh.25773. Epub 2020 Mar 26. Am J Hematol. 2020. PMID: 32129510 Free PMC article.
Immune-based therapies in the management of multiple myeloma.
Zanwar S, Nandakumar B, Kumar S. Zanwar S, et al. Among authors: nandakumar b. Blood Cancer J. 2020 Aug 22;10(8):84. doi: 10.1038/s41408-020-00350-x. Blood Cancer J. 2020. PMID: 32829378 Free PMC article. Review.
Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
Nandakumar B, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Siddiqui M, Go RS, Jevremovic D, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Nandakumar B, et al. Mayo Clin Proc. 2021 Mar;96(3):677-687. doi: 10.1016/j.mayocp.2020.06.060. Mayo Clin Proc. 2021. PMID: 33673918 Free PMC article.
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
Evans LA, Go R, Warsame R, Nandakumar B, Buadi FK, Dispenzieri A, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Kourelis TV, Russell S, Lust JA, Lin Y, Siddiqui M, Kyle RA, Gertz MA, Rajkumar SV, Kumar S, Gonsalves WI. Evans LA, et al. Among authors: nandakumar b. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):451-460.e2. doi: 10.1016/j.clml.2021.02.001. Epub 2021 Feb 17. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33785296 Free PMC article.
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States.
Binder M, Nandakumar B, Rajkumar SV, Kapoor P, Buadi FK, Dingli D, Lacy MQ, Gertz MA, Hayman SR, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Gonsalves WI, Russell S, Lin Y, Siddiqui M, Kyle RA, Dispenzieri A, Kumar SK. Binder M, et al. Among authors: nandakumar b. Leukemia. 2022 Mar;36(3):801-808. doi: 10.1038/s41375-021-01453-5. Epub 2021 Oct 26. Leukemia. 2022. PMID: 34702976
Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.
Evans LA, Anderson EA, Jessen E, Nandakumar B, Atilgan E, Jevremovic D, Hitosugi T, Fonseca R, Kumar SK, Gonsalves WI. Evans LA, et al. Among authors: nandakumar b. Am J Hematol. 2022 Jul;97(7):895-902. doi: 10.1002/ajh.26577. Epub 2022 May 6. Am J Hematol. 2022. PMID: 35481878 Free PMC article.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Nandakumar B, Baffour F, Abdallah NH, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Go RS, Kyle RA, Gertz MA, Rajkumar SV, Klug J, Korfiatis P, Gonsalves WI. Nandakumar B, et al. Cancer. 2023 Feb 1;129(3):385-392. doi: 10.1002/cncr.34545. Epub 2022 Nov 22. Cancer. 2023. PMID: 36413412 Free PMC article.
25 results